Amiodarone-induced thyroid disorders: A clinical review

Postgraduate Medical Journal

Volumn 76, Issue 893, 2000, Pages 133-140

  Loh, Keh Chuan ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Amiodarone; Hyperthyroidism; Hypothyroidism; Thyroiditis

Indexed keywords

3,3',5' TRIIODOTHYRONINE; AMIODARONE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CORTICOSTEROID; DEETHYLAMIODARONE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 6; IODINE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; LITHIUM CARBONATE; PERCHLORATE; POTASSIUM PERCHLORATE; PREDNISONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE; THYROID ANTIBODY; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; UNINDEXED DRUG;

CYTOTOXICITY; DIETARY INTAKE; DRUG EFFECT; DRUG INDUCED DISEASE; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; REVIEW; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE METABOLISM; THYROID HORMONE SYNTHESIS; THYROIDITIS; THYROTOXICOSIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; HUMANS; THYROID DISEASES;

EID: 0034058972     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.893.133     Document Type: Review

References (52)

1. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30:791-8.
2. Tisdale JE, Follin SL, Ordelova A, Webb CR. Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995;35: 351-6.
3. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
4. Dong BJ. Thyroid disorders. In: Young LY, Koda Kimble MA, eds. Applied therapeutics: the clinical use of drugs, 6th edn. Vancouver: Applied Therapeutics, Inc,1995; pp 47.1-31.
5. Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986;62:563-8.
6. Vagenakis AG, Downs P, Braverman LE, Burger A, Ingbar SH. Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest 1973;52:528-32.
7. Newman CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998;79:121-7.
8. Hershman JM, Nademanee K, Sugawara M, et al. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol 1986;111:193-9.
9. Kannan R, Ookhtens M, Chopra IJ, Singh BN. Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines. Endocrinology 1984;115:1710-6.
10. Figge HL, Figge J. The effects of amiodarone on thyroid hormone function: a review of physiology and clinical manifestations. J Clin Pharmacol 1990;30:588-95.
11. Wiersinga WW. Amiodarone and the thyroid. In: Weetman AP, Grossman A, eds. Pharmacotherapeutics of the thyroid gland. Berlin: Springer-Verlag, 1997; pp225-87.
12. Kaptein EM, Egodage PM, Hoopes MT, Burger AG. Amiodarone alters thyroxine transfer and distribution in humans. Metabolism 1988;37: 1107-13.
13. Norman MF, Lavin TN. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. J Clin Invest 1989;83:306-13.
14. de Jong M, Docter R, van der Hoek H, et al. Different effects of amiodarone on transport of T4 and T3 into die perfused rat liver. Am J Physiol 1994;266:E44-9.
15. Singh BN, Collett JT, Chew CYC. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980; 22:243-301.
16. Drvota V, Blange I, Haggblad J, Sylven C. Desethylamiodarone prolongation of cardiac repolarization is dependent on gene expression: a novel antiarrhythmic mechanism. J Cardiovasc Pharmacol 1998;32:654-61.
17. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res 1997;35:13-29.
18. van Beeren HC, Bakker O, Wiersinga WM. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha 1- and beta 1-thyroid hormone receptor by amiodarone analogs. Endocrinology 1996;137: 2807-14.
19. Perret G, Yin YL, Nicolas P, et al. Amiodarone decreases cardiac beta-adrenoreceptors through an antagonistic effect on 3,5,3'triiodothyronine. J Cardiovasc Pharmacol 1992;19:473-8.
20. Yin YL, Perret GY, Nicolas P, Vassy R, Uzzan B, Tod M. In vivo effects of amiodarone on cardiac beta-adrenoceptor density and heart rate require thyroid hormones. J Cardiovasc Pharmacol 1992;19:541-5.
21. Yin Y, Vassy R, Nicolas P, Perret GY, Laurent S. Antagonism between T3 and amiodarone on the contractility and the density of beta-adrenoceptors of chicken cardiac myocytes. Eur J Pharmacol 1994;261:97-104.
22. Bergman M, Cohen F, Schlesinger H, Kessler-Icekson G. Effects of amiodarone on beating rate and Na-K-ATPase activity in cultured neonatal rat heart myocytes. Gen Pharmacol 1995; 26:285-90.
23. Lubic SP, Nguyen KP, Dave B, Giacommi JC. Antiarrhythmic agent amiodarone possesses calcium channel blocker properties. J Cardiovasc Pharmacol 1994;24:707-14.
24. Iervasi G, Clerico A, Bonini R, et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997;82:275-80.
25. Lambert MJ, Burger AG, Galeazzi RL, Engler D. Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism? J Clin Endocrinol Metab 1982;55:1058-65.
26. Lambert M, Burger AG, de Nayer, Beckers C. Decreased TSH response to TRH induced by amiodarone. Acta Endocrinol (Copenh) 1988; 118:449-52.
27. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 1987;26:227-37.
28. Martino E, Bartalena L, Mariotti S, et al. Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction Acta Endocrinol 1988;119:167-73.
29. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984;101:28-34.
30. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;91:507-11.
31. Martine E, Mariotti S, Aghini-Lombardi F, et al Short term administration of potassium perchlorate restores euthyroidism in amiodarone-induced hypothyroidism. J Clin Endocrinol Metab 1986;63:1233-6.
32. van Dam EW, Prummel MF, Wiersinga WM, Nikkels RE. Treatment of amiodarone-induced hypothyroidism with potassium perchlorate. Neth J Med 1993;42:21-4.
33. Brennan MD, Erickson DZ, Carney JA, Bahn RS. Nongoitrous amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 1995;5:177-83.
34. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 1987;11:197-204.
35. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-7.
36. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996;81:2930-3.
37. Trip MD, Duren DR, Wiersinga WM. Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. Br Heart J 1994;72:266-8.
38. Cappiello E, Boldorini R, Tosoni A, Piraneo S, Bernasconi R, Raggi U. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis. J Endocrinol Invest 1995;18:862-8.
39. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res 1987;26:158-71.
40. Martino E, Aghini-Lombardi F, Lippi F, et al. Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med 1985;26:1402-7.
41. Bogazzi F, Bartalena L, Brogioni S, et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997;7:541-5.
42. Davies PH, Franklyn JA, Sheppard MC. Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. BMJ 1992;305:224-5.
43. Reichert LJM, de Rooy HAM. Treatment of amiodarone induced hyperthyroidism with potassium percholate and methimazole during amiodarone treatment. BMJ 1989;298:1547-8.
44. Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev 1998;50:89-105.
45. Martino E, Aghini-Lambardi F, Mariotti S, et al. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 1986;9:201-7.
46. Broussolle C, Ducottet X, Martin C, et al. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis: comparison of two groups of patients with apparently normal glands. J Endocrinol Invest 1989;12:37-42.
47. Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S. Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 1997;102:454-8.
48. Lesar TS, Tollefson G. Lithium therapy. Careful workup, close follow-up to avoid toxicity. Postgrad Med 1984;75:269-76; 281-6.
49. Brennan MD, van Heerden JA, Carney JA. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery 1987;102:1062-7.
50. Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J, Hennen G. Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J Surg 1998;22:537-43.
51. Uzzan B, Pussard E, Leon A, et al. The effects of plasmapharesis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis (letter). Br J Clin Pharmacol 1991;31:371-2.
52. Samaras K, Marel GM. Failure of plasmapharesis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis. Clin Endocrinol 1996;45:365-8.